Status:
COMPLETED
Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Conditions:
Breast Cancers
Eligibility:
FEMALE
25+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.
Detailed Description
To evaluate the proportions of correct diagnosis of response to breast Cancer therapies for localized breast cancer by ultrasound. To develop a model based on patient characteristics, physical exam, a...
Eligibility Criteria
Inclusion
- Newly diagnosed breast cancer prior to receiving breast cancer therapy.
- Diagnosis of breast cancer must be confirmed by fine needle aspiration or core biopsy.
Exclusion
- Poorly controlled diabetes.
- Contralateral mastectomy prior to neoadjuvant chemotherapy.
- Not a surgical candidate.
- No previous axillary lymph node dissection.
Key Trial Info
Start Date :
March 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00721903
Start Date
March 1 2000
End Date
September 1 2014
Last Update
May 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan Hospital
Ann Arbor, Michigan, United States, 48109